Invention Grant
- Patent Title: Recombinant polypeptides for membrane fusion and uses thereof
-
Application No.: US13877101Application Date: 2011-09-29
-
Publication No.: US10227386B2Publication Date: 2019-03-12
- Inventor: Roy Duncan , Eileen Kathryn Clancy , John Lewis , Roberto Justo De Antueno , Rae-Lynn Nesbitt
- Applicant: Roy Duncan , Eileen Kathryn Clancy , John Lewis , Roberto Justo De Antueno , Rae-Lynn Nesbitt
- Applicant Address: CA Edmonton
- Assignee: Entos Pharmaceuticals Inc.
- Current Assignee: Entos Pharmaceuticals Inc.
- Current Assignee Address: CA Edmonton
- Agency: Haynes and Boone, LLP
- International Application: PCT/CA2011/001088 WO 20110929
- International Announcement: WO2012/040825 WO 20120405
- Main IPC: C07K14/46
- IPC: C07K14/46 ; C07K14/01 ; A61K9/127 ; C12N15/113 ; C12N15/11

Abstract:
Disclosed is a recombinant polypeptide for facilitating membrane fusion. The recombinant polypeptide having a sequence with at least 80% sequence identity with the ectodomain of p14 fusion-associated small transmembrane (FAST) protein and having a functional myristoylation motif, a transmembrane domain from a FAST protein and a sequence with at least 80% sequence identity with the endodomain of p15 FAST protein. A targeting ligand can be added to the recombinant polypeptide for selective fusion. The recombinant polypeptide can be included in the membrane of a liposome, or the like, to facilitate the delivery of bioactive compounds, such as siRNA, or the recombinant polypeptide can be mixed with a lipid carrier and added to cultured cells to induce cell-cell fusion and heterokaryon formation.
Public/Granted literature
- US20140314831A1 RECOMBINANT POLYPEPTIDES FOR MEMBRANE FUSION AND USES THEREOF Public/Granted day:2014-10-23
Information query